Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 21, 2014; 20(39): 14348-14358
Published online Oct 21, 2014. doi: 10.3748/wjg.v20.i39.14348
Published online Oct 21, 2014. doi: 10.3748/wjg.v20.i39.14348
Table 3 Comparison of outcomes of ablative techniques
Ref. | Publication year | Mode of therapy | Number of patients ablated | Median PFS | Median OS |
Taner et al[34] | 2012 | RFA and extra-hepatic resection | 94 | 24 mo | |
Karabulut et al[25] | 2011 | RFA | 69 | 10.5 mo | 73 mo |
Akyildiz et al[44] | 2010 | RFA | 30 | 15.6 mo | 72 mo |
Martin et al[45] | 2010 | MWA and extra-hepatic resection | 11 | 8 mo | 18 mo |
Mazzaglia et al[46] | 2007 | RFA and extra-hepatic resection | 63 | 47 mo | |
Gillams et al[47] | 2005 | RFA | 25 | 29 mo | |
Seifert et al[49] | 1998 | Cryotherapy | 13 | 103 mo | |
Shapiro et al[50] | 1998 | Cryotherapy | 5 | 1 | |
Bilchik et al[51] | 1997 | Cryotherapy | 19 | 10 mo | 49 mo |
- Citation: Alagusundaramoorthy SS, Gedaly R. Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor. World J Gastroenterol 2014; 20(39): 14348-14358
- URL: https://www.wjgnet.com/1007-9327/full/v20/i39/14348.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i39.14348